Skip to Content
Blockchain

A few big players may have been behind Bitcoin’s huge surge last year

June 13, 2018

New research (PDF) suggests that a price manipulation scheme may have been behind the cryptocurrency’s extraordinary rally in 2017.

The study: Researchers at the University of Texas analyzed blockchain data and found that large purchases of cryptocurrency from multiple trading platforms in exchange for Tether, a crypto-token that’s supposedly pegged to the US dollar, were “timed following market downturns” and, since cryptocurrency prices tend to move as one, resulted in “sizable increases in Bitcoin prices.” This suggests, according to the New York Times, that a few players may have been propping up the price of Bitcoin and other large cryptocurrencies.

The shady backstory: As the price of Bitcoin was soaring last fall, suspicions began to emerge that Tether (which has never shown proof that all its tokens are actually backed up by cash) was being used to boost the price. Leaked documents revealed that the operators of Bitfinex, one of the world’s most popular cryptocurrency exchanges, were also behind Tether. In December, US financial regulators subpoenaed Bitfinex.

Peeling back the curtain: The findings come as the US Department of Justice is in the midst of a criminal investigation, which it launched last month, into cryptocurrency price manipulation.

Keep Reading

Most Popular

open sourcing language models concept
open sourcing language models concept

Meta has built a massive new language AI—and it’s giving it away for free

Facebook’s parent company is inviting researchers to pore over and pick apart the flaws in its version of GPT-3

transplant surgery
transplant surgery

The gene-edited pig heart given to a dying patient was infected with a pig virus

The first transplant of a genetically-modified pig heart into a human may have ended prematurely because of a well-known—and avoidable—risk.

Muhammad bin Salman funds anti-aging research
Muhammad bin Salman funds anti-aging research

Saudi Arabia plans to spend $1 billion a year discovering treatments to slow aging

The oil kingdom fears that its population is aging at an accelerated rate and hopes to test drugs to reverse the problem. First up might be the diabetes drug metformin.

Yann LeCun
Yann LeCun

Yann LeCun has a bold new vision for the future of AI

One of the godfathers of deep learning pulls together old ideas to sketch out a fresh path for AI, but raises as many questions as he answers.

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.